Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance.
- NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance.
- NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_assertion evidence source_evidence_literature NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance.
- NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_assertion SIO_000772 14578204 NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance.
- NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_assertion wasDerivedFrom befree-20150227 NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance.
- NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_assertion wasGeneratedBy ECO_0000203 NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance.